154 related articles for article (PubMed ID: 31604115)
1. RETRACTED: Endogenous production of C-C motif chemokine ligand 2 by nasopharyngeal carcinoma cells drives radioresistance-associated metastasis.
Guo SS; Liu R; Wen YF; Liu LT; Yuan L; Li YX; Li Y; Hao WW; Peng JY; Chen DN; Tang QN; Sun XS; Guo L; Mo HY; Qian CN; Zeng MS; Bei JX; Sun SY; Chen QY; Tang LQ; Mai HQ
Cancer Lett; 2020 Jan; 468():27-40. PubMed ID: 31604115
[TBL] [Abstract][Full Text] [Related]
2. Retraction notice to "Endogenous production of C-C motif chemokine ligand 2 by nasopharyngeal carcinoma cells drives radioresistance-associated metastasis" [Canc. Lett. 468 (2020) 27-40].
Guo SS; Liu R; Wen YF; Liu LT; Yuan L; Li YX; Lie Y; Hao WW; Peng JY; Chen DN; Tang QN; Sun XS; Guo L; Mo HY; Qian CN; Zeng MS; Bei JX; Sun SY; Chen QY; Tang LQ; Mai HQ
Cancer Lett; 2023 Apr; 558():216061. PubMed ID: 36813649
[TBL] [Abstract][Full Text] [Related]
3. RETRACTED: Neuroendocrine differentiation contributes to radioresistance development and metastatic potential increase in non-small cell lung cancer.
Zhu R; Yang X; Xue X; Shen M; Chen F; Chen X; Tsai Y; Keng PC; Chen Y; Lee SO; Chen Y
Biochim Biophys Acta Mol Cell Res; 2018 Dec; 1865(12):1878-1890. PubMed ID: 30262435
[TBL] [Abstract][Full Text] [Related]
4. RETRACTED: MicroRNA-361-5p inhibits papillary thyroid carcinoma progression by targeting ROCK1.
Li R; Dong B; Wang Z; Jiang T; Chen G
Biomed Pharmacother; 2018 Jun; 102():988-995. PubMed ID: 29710554
[TBL] [Abstract][Full Text] [Related]
5. RETRACTED: EMP3, which is regulated by miR-663a, suppresses gallbladder cancer progression via interference with the MAPK/ERK pathway.
Ma Q; Zhang Y; Liang H; Zhang F; Liu F; Chen S; Hu Y; Jiang L; Hao Y; Li M; Liu Y
Cancer Lett; 2018 Aug; 430():97-108. PubMed ID: 29778567
[TBL] [Abstract][Full Text] [Related]
6. RETRACTED: PINK1 deficiency in gastric cancer compromises mitophagy, promotes the Warburg effect, and facilitates M2 polarization of macrophages.
Xu Y; Lu J; Tang Y; Xie W; Zhang H; Wang B; Zhang S; Hou W; Zou C; Jiang P; Zhang W
Cancer Lett; 2022 Mar; 529():19-36. PubMed ID: 34979165
[TBL] [Abstract][Full Text] [Related]
7. Retraction notice to "PINK1 deficiency in gastric cancer compromises mitophagy, promotes the Warburg effect, and facilitates M2 polarization of macrophages" [Cancer Lett. 529 (2022) 19-36].
Xu Y; Lu J; Tang Y; Xie W; Zhang H; Wang B; Zhang S; Hou W; Zou C; Jiang P; Zhang W
Cancer Lett; 2022 Nov; 549():215931. PubMed ID: 36216652
[TBL] [Abstract][Full Text] [Related]
8. RETRACTED: Up-regulating ribonuclease inhibitor inhibited epithelial-to-mesenchymal transition and metastasis in murine melanoma cells.
Pan X; Xiong D; Yao X; Xin Y; Zhang L; Chen J
Int J Biochem Cell Biol; 2012 Jun; 44(6):998-1008. PubMed ID: 22465710
[TBL] [Abstract][Full Text] [Related]
9. RETRACTED: MicroRNA-138 modulates metastasis and EMT in breast cancer cells by targeting vimentin.
Zhang J; Liu D; Feng Z; Mao J; Zhang C; Lu Y; Li J; Zhang Q; Li Q; Li L
Biomed Pharmacother; 2016 Feb; 77():135-41. PubMed ID: 26796277
[TBL] [Abstract][Full Text] [Related]
10. EVI1 promotes epithelial-to-mesenchymal transition, cancer stem cell features and chemo-/radioresistance in nasopharyngeal carcinoma.
Lu Y; Liang Y; Zheng X; Deng X; Huang W; Zhang G
J Exp Clin Cancer Res; 2019 Feb; 38(1):82. PubMed ID: 30770775
[TBL] [Abstract][Full Text] [Related]
11. Targeting Epstein-Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapy.
Hu J; Li Y; Li H; Shi F; Xie L; Zhao L; Tang M; Luo X; Jia W; Fan J; Zhou J; Gao Q; Qiu S; Wu W; Zhang X; Liao W; Bode AM; Cao Y
Theranostics; 2020; 10(26):11921-11937. PubMed ID: 33204320
[TBL] [Abstract][Full Text] [Related]
12. Induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by chemoradiotherapy in patients with stage III-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised, controlled, phase 3 trial.
Lv X; Cao X; Xia WX; Liu KY; Qiang MY; Guo L; Qian CN; Cao KJ; Mo HY; Li XM; Li ZH; Han F; He YX; Liu YM; Wu SX; Bai YR; Ke LR; Qiu WZ; Liang H; Liu GY; Miao JJ; Li WZ; Lv SH; Chen X; Zhao C; Xiang YQ; Guo X
Lancet Oncol; 2021 May; 22(5):716-726. PubMed ID: 33857411
[TBL] [Abstract][Full Text] [Related]
13. RETRACTED: LncRNA SNHG3 promotes the growth and metastasis of colorectal cancer by regulating miR-539/RUNX2 axis.
Dacheng W; Songhe L; Weidong J; Shutao Z; Jingjing L; Jiaming Z
Biomed Pharmacother; 2020 May; 125():110039. PubMed ID: 32187965
[TBL] [Abstract][Full Text] [Related]
14. Concurrent chemoradiotherapy by simultaneously integrated boost volumetric-modulated arc therapy for nasopharyngeal carcinoma-toxicity/quality of life and survival.
Fang FM; Huang TL; Lin YH; Chien CY; Chuang HC; Luo SD; Lin HC; Lin YT; Li SH; Liao KC; Tsai WL
Head Neck; 2019 May; 41(5):1282-1289. PubMed ID: 30548091
[TBL] [Abstract][Full Text] [Related]
15. Prospective, Multicenter, Phase 2 Trial of Induction Chemotherapy Followed by Bio-Chemoradiotherapy for Locally Advanced Recurrent Nasopharyngeal Carcinoma.
Ng WT; Ngan RKC; Kwong DLW; Tung SY; Yuen KT; Kam MKM; Sze HCK; Yiu HHY; Chan LLK; Lung ML; Lee AWM
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):630-638. PubMed ID: 29413277
[TBL] [Abstract][Full Text] [Related]
16. A phase II multicenter randomized controlled trial to compare standard chemoradiation with or without recombinant human endostatin injection (Endostar) therapy for the treatment of locally advanced nasopharyngeal carcinoma: Long-term outcomes update.
Li Y; Tian Y; Jin F; Wu W; Long J; Ouyang J; Zhou Y
Curr Probl Cancer; 2020 Feb; 44(1):100492. PubMed ID: 32035692
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and survival outcomes of ascending, descending and mixed types of nasopharyngeal carcinoma in the non-endemic areas of china: A propensity score matching analysis.
Fan Y; Guan W; Huang R; Lin SY; Song Y; Lu S; Kang L; Yang Q; Lang J; Zhang P
Cancer Med; 2020 Dec; 9(24):9315-9325. PubMed ID: 33058559
[TBL] [Abstract][Full Text] [Related]
18. RETRACTED: KDM5B-mediated microRNA-448 up-regulation restrains papillary thyroid cancer cell progression and slows down tumor growth via TGIF1 repression.
Pu Y; Xiang J; Zhang J
Life Sci; 2020 Jun; 250():117519. PubMed ID: 32147429
[TBL] [Abstract][Full Text] [Related]
19. RETRACTED: Selective targeting of checkpoint kinase 1 in tumor cells with a novel potent oncolytic adenovirus.
Gao Q; Zhou J; Huang X; Chen G; Ye F; Lu Y; Li K; Zhuang L; Huang M; Xu G; Wang S; Ma D
Mol Ther; 2006 May; 13(5):928-937. PubMed ID: 16459149
[TBL] [Abstract][Full Text] [Related]
20. Short-term outcomes of induction chemotherapy with docetaxel, cisplatin, and fluorouracil (TPF) in locally advanced nasopharyngeal carcinoma.
Takamizawa S; Honma Y; Murakami N; Mori T; Oka H; Yamamoto S; Kashihara T; Ito K; Kubo Y; Ikeda A; Matsumoto F; Omura G; Kobayashi K; Itami J; Kato K; Yoshimoto S
Invest New Drugs; 2021 Apr; 39(2):564-570. PubMed ID: 32940872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
